Halozyme Therapeutics
HALO
$33.57
Share price
3.32%
Change (1 day)
-24.48%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : $1.67 B
According to Halozyme Therapeutics's latest financial reports the company's total liabilities are $1.67 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $1.67 B | 84.22% |
| 2021-12-31 | $0.90 B | 111.59% |
| 2020-12-31 | $0.42 B | -9.54% |
| 2019-12-31 | $0.47 B | 147.76% |
| 2018-12-31 | $0.19 B | -38.58% |
| 2017-12-31 | $0.31 B | 5.98% |
| 2016-12-31 | $0.29 B | 111.83% |
| 2015-12-31 | $0.13 B | 11.37% |
| 2014-12-31 | $0.12 B | 2.33% |
| 2013-12-31 | $0.12 B | 41.82% |
| 2012-12-31 | $85.87 M | 56.54% |
| 2011-12-31 | $54.85 M | -22.73% |
| 2010-12-31 | $70.99 M | 1.06% |
| 2009-12-31 | $70.24 M | 14.81% |
| 2008-12-31 | $61.18 M | 33.9% |
| 2007-12-31 | $45.69 M | 98.58% |
| 2006-12-31 | $23.01 M | 898.98% |
| 2005-12-31 | $2.3 M | 45.84% |
| 2004-12-31 | $1.57 M | 4117.05% |
| 2003-12-31 | $0.03 M | 258.95% |
| 2002-12-31 | $0.01 M | 217.24% |
| 2001-12-31 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $110.57 B | 6,514.42% | 🇺🇸 USA |
 Pfizer PFE | $101.28 B | 5,959.01% | 🇺🇸 USA |
 Eli Lilly LLY | $41.86 B | 2,404.51% | 🇺🇸 USA |
 Sanofi SNY | $55.23 B | 3,203.81% | 🇫🇷 France |
 Baxter BAX | $22.35 B | 1,236.95% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.54 B | -67.35% | 🇺🇸 USA |